Initial Treatment Approach for Primary Hypertension
The initial treatment approach for primary hypertension should include lifestyle modifications for all patients, with immediate pharmacological therapy initiated for Grade 2 hypertension (≥160/100 mmHg) or Grade 1 hypertension (140-159/90-99 mmHg) with high cardiovascular risk, target organ damage, diabetes, or CKD. 1
Diagnosis and Assessment
Hypertension is diagnosed when blood pressure is persistently elevated, with diagnosis confirmed through:
- Office BP measurements (at least 2 readings, averaged)
- Home BP monitoring
- 24-hour ambulatory BP monitoring 1
Classification of hypertension:
- Normal BP: <130/85 mmHg
- Elevated BP: 130-139/85-89 mmHg
- Grade 1 hypertension: 140-159/90-99 mmHg
- Grade 2 hypertension: ≥160/100 mmHg 1
Lifestyle Modifications
Lifestyle modifications are recommended for all patients with elevated blood pressure or hypertension:
Dietary modifications:
- DASH diet (rich in fruits, vegetables, low-fat dairy)
- Sodium restriction (<2,300 mg/day)
- Increased potassium intake
- Moderate alcohol consumption (≤2 drinks/day for men, ≤1 drink/day for women) 1
Physical activity:
- At least 30 minutes of moderate-intensity aerobic exercise 5-7 days/week (can reduce BP by 4-9 mmHg) 1
Weight management:
- Target BMI <25 kg/m²
- Weight loss in overweight/obese patients can reduce BP by 5-20 mmHg 1
Other recommendations:
- Smoking cessation
- Stress management techniques 1
These lifestyle interventions have been shown to have antihypertensive effects similar to pharmacologic monotherapy 2 and can be effective in preventing or controlling stage 1 hypertension 3.
Pharmacological Therapy
When to Initiate Medication
Immediate initiation of pharmacological therapy for:
- Grade 2 hypertension (≥160/100 mmHg)
- Grade 1 hypertension (140-159/90-99 mmHg) with high CV risk, target organ damage, diabetes, CKD, or age 50-80 years 1
After 3-6 months of lifestyle modifications for patients with persistent Grade 1 hypertension without the above risk factors 1
First-Line Medication Options
Four main classes of medications are recommended as first-line therapy:
ACE inhibitors (e.g., lisinopril)
- Initial dose: 10 mg once daily
- Usual dosage range: 20-40 mg per day 4
Angiotensin II receptor blockers (ARBs) (e.g., losartan)
Dihydropyridine calcium channel blockers
Thiazide or thiazide-like diuretics 1
Population-Specific Recommendations
For non-Black patients:
- Initial therapy: low-dose ACE inhibitor/ARB
- Alternatives: dihydropyridine calcium channel blockers or thiazide-like diuretics 1
For Black patients:
- Initial therapy: low-dose ARB + dihydropyridine calcium channel blocker or a dihydropyridine calcium channel blocker + thiazide-like diuretic 1
For patients with diabetes:
Treatment Goals and Monitoring
Target blood pressure:
Monitoring:
- Monthly visits until blood pressure targets are achieved
- Reassessment within 2-4 weeks to evaluate BP control, medication adherence, and response to treatment
- Laboratory monitoring (serum creatinine and potassium) 7-14 days after initiation or dose change of ACE inhibitors, ARBs, or mineralocorticoid receptor antagonists 1
Combination Therapy
If blood pressure is not controlled with monotherapy:
- Add a second agent from a different class
- Consider low-dose combination therapy, which may be more effective with fewer side effects than higher doses of a single agent
- Most hypertensive patients will require two or more drugs for blood pressure control 5
Common Pitfalls and Caveats
Inadequate lifestyle modifications: Many patients focus solely on medications and neglect the significant impact of lifestyle changes.
White-coat hypertension: Consider ambulatory or home BP monitoring to confirm the diagnosis before initiating therapy.
Medication non-adherence: Use 90-day prescription refills instead of 30-day when BP is controlled, and consider telehealth strategies to improve adherence 1.
Inappropriate diuretic selection: Consider switching to loop diuretics if eGFR <30 ml/min/1.73m² or clinical volume overload 1.
Overlooking secondary causes: Consider screening for secondary causes in patients with resistant hypertension or early-onset hypertension.